跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IMEXA POWDER FOR ORAL SUSPENSION 200MG/5ML - HSA Drug Approval Details
Approvals
/
HSA
/
IMEXA POWDER FOR ORAL SUSPENSION 200MG/5ML
Approved
THERAPEUTIC
IMEXA POWDER FOR ORAL SUSPENSION 200MG/5ML
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
🇸🇬 Health Sciences Authority
Approval Date
Dec 31, 2012
Approval ID
685c256261a296bb
Company
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
Type
Therapeutic
Approval Details
Approval Id
685c256261a296bb
Drug Name
IMEXA POWDER FOR ORAL SUSPENSION 200MG/5ML
Product Name
IMEXA POWDER FOR ORAL SUSPENSION 200MG/5ML
Approval Number
SIN14282P
Approval Date
2012-12-31
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
POWDER, FOR SUSPENSION
Route Of Administration
ORAL
Atc Code
J01FA10
Atc Item Name
azithromycin
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Active Ingredients
Azithromycin Dihydrate 210mg eq to Azithromycin
200mg/5ml
AZITHROMYCIN DIHYDRATE 210 MG EQ TO AZITHROMYCIN
200 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 31, 2012
Approval ID
685c256261a296bb
Type
Therapeutic
Back to HSA Approvals
